US Patent 10471126 Pegylated interleukin-10
Patent 10471126 was granted and assigned to Merck on November, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 6, 2018
0
Date of Patent
November 12, 2019
0
Patent Application Number
15889953
0
Patent Inventor Names
Susan V. Cannon-Carlson
0
David C. Wylie
0
Seoju Lee
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10471126 Pegylated interleukin-10
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.